Skip to content
10-Q

Quarterly Report

HAEMONETICS CORPORATION HAE

0000313143-25-000058

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Aug 1, 2025 48.18M sh
Shares Diluted Q1 2026 · Jun 28, 2025 48.35M sh
Shares Diluted Q1 2026 · Jun 29, 2024 51.56M sh
Capex Q1 2026 · Jun 28, 2025 $3.75M
Capex Q1 2026 · Jun 29, 2024 $5.66M
Operating Cash Flow Q1 2026 · Jun 28, 2025 $17.4M
Operating Cash Flow Q1 2026 · Jun 29, 2024 −$27.42M
Long Term Debt Q1 2026 · Jun 28, 2025 $920.83M
Long Term Debt Q1 2026 · Mar 29, 2025 $921.23M
Cash And Equivalents Q1 2026 · Jun 28, 2025 $292.9M
Cash And Equivalents Q1 2026 · Mar 29, 2025 $306.76M
Stockholders Equity Q1 2026 · Jun 28, 2025 $882.3M
Stockholders Equity Q1 2026 · Mar 29, 2025 $820.84M
Stockholders Equity Q1 2026 · Jun 29, 2024 $905.37M
Stockholders Equity Q1 2026 · Mar 30, 2024 $959.96M
Current Liabilities Q1 2026 · Jun 28, 2025 $531.41M
Current Liabilities Q1 2026 · Mar 29, 2025 $578.11M
Current Assets Q1 2026 · Jun 28, 2025 $913.16M
Current Assets Q1 2026 · Mar 29, 2025 $934.98M
Total Assets Q1 2026 · Jun 28, 2025 $2.46B
Total Assets Q1 2026 · Mar 29, 2025 $2.45B
Eps Diluted Q1 2026 · Jun 28, 2025 $0.70
Eps Diluted Q1 2026 · Jun 29, 2024 $0.74
Eps Basic Q1 2026 · Jun 28, 2025 $0.71
Eps Basic Q1 2026 · Jun 29, 2024 $0.75
Sga Expense Q1 2026 · Jun 28, 2025 $110.72M
Sga Expense Q1 2026 · Jun 29, 2024 $108.25M
Rd Expense Q1 2026 · Jun 28, 2025 $16.26M
Rd Expense Q1 2026 · Jun 29, 2024 $14.45M
Net Income Q1 2026 · Jun 28, 2025 $34.03M
Net Income Q1 2026 · Jun 29, 2024 $38.37M
Operating Income Q1 2026 · Jun 28, 2025 $53.87M
Operating Income Q1 2026 · Jun 29, 2024 $39.76M
Gross Profit Q1 2026 · Jun 28, 2025 $192.24M
Gross Profit Q1 2026 · Jun 29, 2024 $174.92M
Cost Of Revenue Q1 2026 · Jun 28, 2025 $129.15M
Cost Of Revenue Q1 2026 · Jun 29, 2024 $161.25M
Revenue Q1 2026 · Jun 28, 2025 $321.39M
Revenue Q1 2026 · Jun 29, 2024 $336.17M